US · USD
IMVT
Immunovant Inc
- Day's range
- $31.58 – $32.75
- Day's volume
- $22.4M
- 52-week range
- $16.08 – $44.96
Follow IMVT in the Fuolio
See how IMVT weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountIMVT in numbers
- Market cap
- $6.6B
- P/E
- -12.29
- P/B
- 9.00
- Dividend yield (12m)
- 0.00%
IMVT price history
IMVT risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +32.63% | -18.14% | +315.97% |
| Volatility (annualized) | 37.45% | 45.34% | 72.06% |
| Largest drawdown | -21.53% | -65.13% | -65.13% |
| Positive months | 8/12 | 17/36 | 30/60 |
How much did investing in IMVT return?
$1,000.00 invested on 11/01/2021 would be worth $4,159.74 today.
- Value today in IMVT
- $4,159.74
- Return over the period
- +315.97%
- Return per year
- +33.52%
- In the S&P 500
- $1,707.49
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
IMVT fundamentals
Valuation
- P/E-12.29
- P/B9.00
- EV/EBITDA—
- EV/EBIT—
- EV/Revenue—
- P/EBIT—
- P/S—
- P/OCF-16.00
- P/FCF—
- Earnings yield—
- PEG ratio—
- Earnings per share-$2.61
- Book value per share$3.56
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio7.27
- Quick ratio—
- Cash ratio6.81
Profitability
- ROE-73.19%
- ROA-63.13%
- ROIC—
- Payout—
IMVT's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| P/E | -13.01 | -10.50 | -13.95 | -26.04 | -13.19 | — | -68.17 | -45.40 |
| P/B | 7.71 | 6.14 | 5.86 | 15.16 | 4.40 | — | 48.11 | 176.91 |
| Earnings per share | -$2.46 | -$2.42 | -$1.78 | -$1.62 | -$1.35 | — | -$0.68 | -$0.35 |
| Book value per share | $4.15 | $4.14 | $4.23 | $2.78 | $4.03 | — | $0.96 | $0.09 |
| ROE | -59.30% | -58.50% | -41.98% | -58.20% | -33.36% | -27.44% | -70.57% | -389.69% |
IMVT's financial statements
| Line | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net revenue | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| EBITDA | — | — | — | — | — | — |
| EBIT | — | — | — | — | — | — |
| Financial result | — | — | — | — | — | — |
| Income before tax | -$505.4M | -$412.9M | -$258.8M | -$211M | -$156.8M | -$107.8M |
| Income tax | -$215K | -$891K | -$567K | -$9K | $84K | $358K |
| Net income | -$505.6M | -$413.8M | -$259.3M | -$211M | -$156.7M | -$107.4M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does IMVT pay dividends?
IMVT has no distributions on record.
About Immunovant
- Sector
- Manufacturing
Questions about IMVT
How much is IMVT today?
IMVT is at $32.03 (-0.25% on the day), last traded on 10/07/2026.
What are the P/E and P/B of IMVT?
IMVT trades at a P/E of -12.29 and a P/B of 9.00.
How much did IMVT return in 12 months?
IMVT returned 32.63% in 12 months, with annualized volatility of 37.45% and a largest drawdown of -21.53%.